Document is current
Any future updates will be listed below
-
Authors
Vickers, Richard J
Tillotson, Glenn S
Nathan, Richard
Hazan, Sabine
Pullman, John
Lucasti, Christopher
Deck, Kenneth
Yacyshyn, Bruce
Maliakkal, Benedict
Pesant, Yves
Tejura, Bina
Roblin, David
Gerding, Dale N
Wilcox, Mark H
Bhan, Amit
Campbell, Wayne
Chopra, Teena
Deck, Kenneth
Golan, Yoav
Gordon, Ian
Kamepalli, Ravi
Khanna, Sahil
Lee, Christine
Lucasti, Christopher
Maliakkal, Benedict
Minang, Irene
Mullane, Kathleen
Nathan, Richard
Oughton, Matthew
Pesant, Yves
Phillips, John
Pullman, John
Riska, Paul
Schrock, Christian
Siegel, Jonathan
Steinberg, Alon
Talan, David
Tamang, Stephen
Tan, Michael
Weiss, Karl
Wang, Chia
Yacyshyn, Bruce
Young, Jo-Anne
Zenilman, Jonathan
-
License Information
Text and Data Mining valid from 2017-07-01
Version of Record valid from 2017-04-27
-
More Information
This article is maintained by: Elsevier
Article Title: Efficacy and safety of ridinilazole compared with vancomycin for the treatment of Clostridium difficile infection: a phase 2, randomised, double-blind, active-controlled, non-inferiority study
Journal Title: The Lancet Infectious Diseases
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/S1473-3099(17)30235-9
CrossRef DOI link to the associated document: https://doi.org/10.1016/S1473-3099(17)30237-2
Content Type: article
Copyright: © 2017 The Author(s). Published by Elsevier Ltd.
